IPO registrations (S-1, F-1) · Registrants

CardioVascular BioTherapeutics, Inc.

SEC CIK
1303497 · filings on EDGAR ↗
Registration
Form S-1, first filed 2004-09-23, last 2007-06-26; 2 initial registrations, 6 amendments
Outcome
Final prospectus filed 2005-02-15; declared effective 2006-06-12
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1930 VILLAGE CENTER CIRCLE, #3-625, Las Vegas, NV 89134
EIN
33-0795984
EDGAR entity type
operating
Insiders and CEO pay
CardioVascular BioTherapeutics, Inc. on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2005-02-15, an initial public offering)
Shares sold
1,500,000
Gross proceeds
$15,000,000 before underwriting discounts and any over-allotment option
Lead underwriters
First Dunbar Securities Corporation

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 11

FiledFormWhat it isName as filedEDGAR
2004-09-23S-1S-1 (registration)CardioVascular BioTherapeutics, Inc.0001193125-04-160371 ↗
2004-11-26S-1/AS-1/A (amendment)CardioVascular BioTherapeutics, Inc.0001193125-04-203664 ↗
2005-01-13S-1/AS-1/A (amendment)CardioVascular BioTherapeutics, Inc.0001193125-05-005540 ↗
2005-01-31S-1/AS-1/A (amendment)CardioVascular BioTherapeutics, Inc.0001193125-05-015485 ↗
2005-02-04S-1/AS-1/A (amendment)CardioVascular BioTherapeutics, Inc.0001193125-05-020003 ↗
2005-02-10S-1/AS-1/A (amendment)CardioVascular BioTherapeutics, Inc.0001193125-05-025293 ↗
2005-02-15424B4424B4 (final prospectus)CardioVascular BioTherapeutics, Inc.0001193125-05-030392 ↗
2006-06-12EFFECTEFFECT (declared effective)CardioVascular BioTherapeutics, Inc.9999999995-06-000281 ↗
2007-04-19S-1S-1 (registration)CardioVascular BioTherapeutics, Inc.0001193125-07-085327 ↗
2007-06-26S-1/AS-1/A (amendment)CardioVascular BioTherapeutics, Inc.0001193125-07-143120 ↗
2007-06-28EFFECTEFFECT (declared effective)CardioVascular BioTherapeutics, Inc.9999999995-07-002603 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2005-02-10S-1/Aregistration statement$10.001,500,000$15,000,0001primary document; price sentence, shares headline, proceeds table, cover names 1document ↗
2005-02-15424B4final prospectus$10.001,500,000$15,000,0001primary document; price sentence, shares headline, proceeds table, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
MONTANO DANIEL CDirector,Officer,TenPercentOwnerCEO, President, and Chairman; Chairman, CEO & President; Chairman, President & CEO; Chairman, President, CEO; Co-President, CEO & ChaimanBOD; President, CEO & Chairman BOD92006
Stegmann ThomasDirector,Officer,TenPercentOwner; TenPercentOwnerChief Clincial Officer; Chief Clinical Officer; Chief Medical Officer; Co-President & CCO212006–2009
CardioVascular BioTherapeutics, Inc.Director,Officer,TenPercentOwnerVP & Chief Clinical Officer12006
Jacobs John WDirector,OfficerChief Operating Officer & CSO; Chief Scientific Officer; COO and Vice President; COO & Vice President; CSO, COO and Vice President142006–2008
Thomas Kenneth JROfficerVice President R & D; V.P. of Research & Development22006
COOPER C K & CO INC /FA/DirectorOther12006
Flaa MickaelDirector,OfficerChief Financial Officer; Chief Financial Officer & VP; V.P. & CFO32006–2008
C & K Capital CORPDirectorOther22006
Paladin Capital ManagementDirector; DirectorOther32006
Montano Alexander GeneDirector92006
ABROMOVITZ GARY BDirector32006–2007
Baik Joong-KiDirector; Director,TenPercentOwner22006–2007
Gordon GrantDirector; Director,TenPercentOwner42006–2007
HORN SETH AOfficer; OtherCorporate Controller & VP42006–2007
Ingram ThomasDirector22006–2007
Levin Robert SDirector122006–2008
Pelton Judith SOfficerCorporate Secretary22006–2008
Priemer WolfgangDirector; Director,TenPercentOwner302006–2008
ROTH VINCENT JOfficerGeneral Counsel & VP32006–2007
Chanson FredericDirector12008

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2015-01-14CardioVascular BioTherapeutics, Inc.Biotechnology$49,000,000$001

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorCARDIOVASCULAR BIOTHERAPEUTICSNVForm 5500 (employee benefit plans)name and state
Form D issuerCardioVascular BioTherapeutics, Inc.NVForm D private offeringsCIK (EXACT)
Patent assigneeCardioVascular BioTherapeutics, Inc.NVPatents (USPTO)name and state
SEC filerCardioVascular BioTherapeutics, Inc.SEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorCARDIOVASCULAR BIOTHERAPEUTICSEIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NV first:

More with this interest.

In other datasets, the same topic (Health) in NV:

Interests: Pharmaceutical Preparations · Health